Literature DB >> 2104745

Identification of a novel tumor necrosis factor alpha/cachectin from the livers of burned and infected rats.

C Keogh1, Y Fong, M A Marano, S Seniuk, W He, A Barber, J P Minei, D Felsen, S F Lowry, L L Moldawer.   

Abstract

Tumor necrosis factor alpha (TNF-alpha)/cachectin is a monocyte/macrophage-derived cytokine implicated as a proximal mediator of many of the catastrophic host responses to infection or endotoxin. However, circulating levels of TNF-alpha/cachectin have only been episodically detected in hospitalized patients with life-threatening bacterial infections. In the present report, increased quantities of immune-reactive TNF-alpha/cachectin were recovered from the livers of rats 3 days following a lethal burn and infection. Two species of TNF-alpha/cachectin were detected, one of approximately 29 kd and the other 17 kd, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In murine peritoneal macrophages and rat Kupffer cells stimulated in vitro with endotoxin, a 29-kd cell-associated and 17-kd secreted form were also detected. We conclude that the increased appearance in vivo of a 29-kd form of TNF-alpha/cachectin from the livers of lethally burned and infected rats represents a novel cell-associated form of the protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104745     DOI: 10.1001/archsurg.1990.01410130085011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  The pulmonary inflammatory response to experimental fecal peritonitis: relative roles of tumor necrosis factor-alpha and endotoxin.

Authors:  M A Mercer-Jones; M Heinzelmann; J C Peyton; D J Wickel; M Cook; W G Cheadle
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

Review 2.  The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy.

Authors:  T Darville; B Giroir; R Jacobs
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

3.  The comparative efficacy of tyloxapol versus pentoxifylline against induced acute phase response in an ovine experimental endotoxemia model.

Authors:  Aliasghar Chalmeh; Alireza Rahmani Shahraki; Seyed Mohammad Mehdi Heidari; Khalil Badiei; Mehrdad Pourjafar; Saeed Nazifi; Mohammad Javad Zamiri
Journal:  Inflammopharmacology       Date:  2015-12-31       Impact factor: 4.473

4.  Hepatic carbohydrate metabolism in rats after laparotomy and laparoscopy.

Authors:  B Richter; D Inderbitzin; C Lang; S Krähenbühl; L Krähenbühl
Journal:  Surg Endosc       Date:  2005-11       Impact factor: 4.584

5.  Ketamine suppresses intestinal NF-kappa B activation and proinflammatory cytokine in endotoxic rats.

Authors:  Jie Sun; Xiao-Dong Wang; Hong Liu; Jian-Guo Xu
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

Review 6.  Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?

Authors:  Lori F Gentile; Alex G Cuenca; Erin L Vanzant; Philip A Efron; Bruce McKinley; Frederick Moore; Lyle L Moldawer
Journal:  Methods       Date:  2013-05-11       Impact factor: 3.608

Review 7.  Alcohol's Burden on Immunity Following Burn, Hemorrhagic Shock, or Traumatic Brain Injury.

Authors:  Patricia E Molina; Paige S Katz; Flavia Souza-Smith; Stephen M Ford; Sophie X Teng; Tracy Y Dodd; John K Maxi; Jacques P Mayeux
Journal:  Alcohol Res       Date:  2015

8.  Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses.

Authors:  M A Rogy; T Auffenberg; N J Espat; R Philip; D Remick; G K Wollenberg; E M Copeland; L L Moldawer
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

Review 9.  Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.

Authors:  M A Rogy; Julie M Baumhofer; Britta Beinhauer; H Brandmeier; P Eisenburger; U M Losert; Ramila Philip
Journal:  Acta Chir Austriaca       Date:  1997
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.